1. Home
  2. GLBE vs TLX Comparison

GLBE vs TLX Comparison

Compare GLBE & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global-E Online Ltd.

GLBE

Global-E Online Ltd.

HOLD

Current Price

$40.74

Market Cap

6.9B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.88

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBE
TLX
Founded
2013
2015
Country
Israel
Australia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
3.3B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GLBE
TLX
Price
$40.74
$7.88
Analyst Decision
Buy
Strong Buy
Analyst Count
13
4
Target Price
$49.46
$21.00
AVG Volume (30 Days)
1.4M
146.9K
Earning Date
11-19-2025
01-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
0.04
Revenue
$888,450,000.00
$664,225,558.00
Revenue This Year
$29.10
N/A
Revenue Next Year
$24.09
N/A
P/E Ratio
$951.83
$183.16
Revenue Growth
31.57
55.35
52 Week Low
$26.64
$7.72
52 Week High
$63.69
$30.36

Technical Indicators

Market Signals
Indicator
GLBE
TLX
Relative Strength Index (RSI) 59.27 29.21
Support Level $38.41 $7.72
Resistance Level $40.62 $10.03
Average True Range (ATR) 1.36 0.27
MACD -0.04 -0.18
Stochastic Oscillator 69.79 8.23

Price Performance

Historical Comparison
GLBE
TLX

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: